---
category: news
title: "Poor data is hindering machine learning, US drug development, study says"
excerpt: "A lack of proper data is hurting the use of machine learning to develop drugs, which could put U.S. drugmakers at a competitive disadvantage compared to other countries, according to a report from the U.S. Government Accountability Office and the National Academy of Medicine. Machine learning is a type of artificial intelligence that involves ..."
publishedDateTime: 2020-01-23T19:08:00Z
sourceUrl: "https://www.beckershospitalreview.com/pharmacy/poor-data-is-hindering-machine-learning-us-drug-development-study-says.html"
type: article
quality: 38
heat: -1
published: false

provider:
  name: Becker's Hospital Review
  domain: beckershospitalreview.com

topics:
  - AI
  - Machine Learning

images:
  - url: "https://www.beckershospitalreview.com/images/channels/pharmacy/3.jpg"
    width: 400
    height: 300
    title: "Poor data is hindering machine learning, US drug development, study says"

related:
  - title: "Data challenges hinder machine learning in drug development"
    excerpt: "While machine learning has the potential to identify new treatments, reduce failure rates in clinical trials and improve drug development, a lack of high-quality data is hindering the use of the technology. Thatâ€™s among the findings of a new report ..."
    publishedDateTime: 2020-01-22T05:25:00Z
    sourceUrl: "https://www.healthdatamanagement.com/news/data-challenges-hinder-machine-learning-in-drug-development"
    type: article
    provider:
      name: Health Data Management
      domain: healthdatamanagement.com
    quality: 39
    images:
      - url: "https://sourcemedia.brightspotcdn.com/dims4/default/1c53273/2147483647/strip/true/crop/4000x2100+0+284/resize/1200x630!/quality/90/?url=https%3A%2F%2Fsourcemedia.brightspotcdn.com%2Fb2%2Ffb%2F50858dbb4b34bc5539847a86c8c6%2Fdrug-research-090816-a.jpg"
        width: 1200
        height: 630
  - title: "Machine Learning in Drug Development Requires Data Access, Standards"
    excerpt: "January 22, 2020 - Machine learning algorithms have the potential to accelerate and refine the drug development process, but the industry should expand data access and create consistent data standards to ensure drug companies can fully leverage these tools, according to a report from the Government Accountability Office (GAO). Drug companies ..."
    publishedDateTime: 2020-01-22T16:15:00Z
    sourceUrl: "https://healthitanalytics.com/news/machine-learning-in-drug-development-requires-data-access-standards"
    type: article
    provider:
      name: Analytics
      domain: healthitanalytics.com
    quality: 19

secured: "Zq5mKWI8gmmBBfKabAFGGbiMmpWjEh5i4dAFq3yK8wxfD57jpGby86b2Efllks3Mv2h/ISgsLICMLDmFAxI1rUMK+/Nf2jaNvVhU331Y/WfevCF8oIx4RSQ7STK3gG4Qmh8C8ew3zYBv40ZF7QQ3n0hanlLz06Hpob+MBq5Uo7l1ezVa/JJNdmwMT4tiQQaggZE1RUuYRits8Tu33/HdiTrDzYCkCtYnKEquwYo0HW2RP4lzIRPW/8DHHLwfZGr5NA9kfjK+tCgnefm/2tBQ36E4QWpfLf45Eb0ux9BLro2DlK+wh7T48hjrb5wKWE7o;TyTD0Tn/wudcaC5Ja/ga3A=="
---

